AAAAAA

   
Results: 1-9 |
Results: 9
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma
Authors: Dudley, ME Wunderlich, J Nishimura, MI Yu, D Yang, JC Topalian, SL Schwartzentruber, DJ Hwu, P Marincola, FM Sherry, R Leitman, SF Rosenberg, SA
Citation: Me. Dudley et al., Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma, J IMMUNOTH, 24(4), 2001, pp. 363-373
TCR stimulation protects CD8(+) T cells from CD95 mediated apoptosis
Authors: Karas, M Zaks, TZ Yakar, S Dudley, ME LeRoith, D
Citation: M. Karas et al., TCR stimulation protects CD8(+) T cells from CD95 mediated apoptosis, HUMAN IMMUN, 62(1), 2001, pp. 32-38
Efficient chromosomal mapping of a methylcholanthrene-induced tumor antigen by CTL immunoselection
Authors: Akilesh, S Dudley, ME Eden, PA Roopenian, DC
Citation: S. Akilesh et al., Efficient chromosomal mapping of a methylcholanthrene-induced tumor antigen by CTL immunoselection, J IMMUNOL, 167(9), 2001, pp. 5143-5149
Kinetics of TCR use in response to repeated epitope-specific immunization
Authors: Monsurro, V Nielsen, MB Perez-Diez, A Dudley, ME Wang, E Rosenberg, SA Marincola, FM
Citation: V. Monsurro et al., Kinetics of TCR use in response to repeated epitope-specific immunization, J IMMUNOL, 166(9), 2001, pp. 5817-5825
T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes
Authors: Dudley, ME Ngo, LT Westwood, J Wunderlich, JR Rosenberg, SA
Citation: Me. Dudley et al., T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes, CANCER J, 6(2), 2000, pp. 69-77
Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer
Authors: Parker, LL Do, MT Westwood, JA Wunderlich, JR Dudley, ME Rosenberg, SA Hwu, P
Citation: Ll. Parker et al., Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer, HUM GENE TH, 11(17), 2000, pp. 2377-2387
CD4(+) T cell control of CD8(+) T cell reactivity to a model tumor antigen
Authors: Surman, DR Dudley, ME Overwijk, WW Restifo, NP
Citation: Dr. Surman et al., CD4(+) T cell control of CD8(+) T cell reactivity to a model tumor antigen, J IMMUNOL, 164(2), 2000, pp. 562-565
Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads toa functionally heterogeneous CTL response
Authors: Dudley, ME Nishimura, MI Holt, AKC Rosenberg, SA
Citation: Me. Dudley et al., Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads toa functionally heterogeneous CTL response, J IMMUNOTH, 22(4), 1999, pp. 288-298
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy
Authors: Zeh, HJ Perry-Lalley, D Dudley, ME Rosenberg, SA Yang, JC
Citation: Hj. Zeh et al., High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy, J IMMUNOL, 162(2), 1999, pp. 989-994
Risultati: 1-9 |